JPM Thematics - Genetic Therapies C Fonds
60,39
GBP
+0,77
GBP
+1,29
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Vertex Pharmaceuticals Inc | US92532F1003 | 3,42% |
| Novartis AG Registered Shares | CH0012005267 | 3,39% |
| Gilead Sciences Inc | US3755581036 | 3,37% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 3,31% |
| PTC Therapeutics Inc | US69366J2006 | 3,27% |
| Vericel Corp | US92346J1088 | 3,25% |
| Lonza Group Ltd | CH0013841017 | 3,23% |
| Bristol-Myers Squibb Co | US1101221083 | 3,22% |
| Bio-Techne Corp | US09073M1045 | 3,12% |
| Amgen Inc | US0311621009 | 2,99% |
| Sonstige | 67,41% |